Your browser doesn't support javascript.
loading
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma.
Haddad, Robert I; Seiwert, Tanguy Y; Chow, Laura Q M; Gupta, Shilpa; Weiss, Jared; Gluck, Iris; Eder, Joseph P; Burtness, Barbara; Tahara, Makoto; Keam, Bhumsuk; Kang, Hyunseok; Muro, Kei; Albright, Andrew; Mogg, Robin; Ayers, Mark; Huang, Lingkang; Lunceford, Jared; Cristescu, Razvan; Cheng, Jonathan; Mehra, Ranee.
Afiliação
  • Haddad RI; Department of Medical Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA Robert_Haddad@dfci.harvard.edu.
  • Seiwert TY; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, USA.
  • Chow LQM; Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Gupta S; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Weiss J; Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, North Carolina, USA.
  • Gluck I; Department of Oncology, Sheba Medical Center at Tel HaShomer, Ramat Gan, Israel.
  • Eder JP; Department of Medicine, Medical Oncology, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.
  • Burtness B; Division of Medical Oncology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.
  • Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kang H; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland, USA.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Albright A; Merck & Co., Inc, Kenilworth, New Jersey, USA.
  • Mogg R; Merck & Co., Inc, Kenilworth, New Jersey, USA.
  • Ayers M; Merck & Co., Inc, Kenilworth, New Jersey, USA.
  • Huang L; Merck & Co., Inc, Kenilworth, New Jersey, USA.
  • Lunceford J; Merck & Co., Inc, Kenilworth, New Jersey, USA.
  • Cristescu R; Merck & Co., Inc, Kenilworth, New Jersey, USA.
  • Cheng J; Merck & Co., Inc, Kenilworth, New Jersey, USA.
  • Mehra R; Department of Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
J Immunother Cancer ; 10(2)2022 02.
Article em En | MEDLINE | ID: mdl-35217573
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carga Tumoral / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Transcriptoma / Antineoplásicos Imunológicos / Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço / Imunoterapia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carga Tumoral / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Transcriptoma / Antineoplásicos Imunológicos / Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço / Imunoterapia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article